Archive | HAPILA GmbH
CEP Revision extends HAPILA Estriol API retest period to 60 months
Thursday 23rd June 2022
Learn More >
HAPILA extends co-operation with Transo-Pharm to meet Estriol demand
Tuesday 8th March 2022
Learn More >
Authorities confirm cGMP status for HAPILA’s Estriol estrogen API manufacturing
Thursday 17th February 2022
Learn More >
HAPILA starts optimized pilot scale production of BTZ-043 anti TB agent
Thursday 13th January 2022
Learn More >
HAPILA GMP focused API contract development and manufacturing
Thursday 23rd December 2021
Learn More >
HAPILA reaching completion of design for new GMP production plant for APIs
Thursday 26th August 2021
Learn More >
Authorities extend CEP certification for HAPILA’s Estriol estrogen API
Tuesday 2nd March 2021
Learn More >
